Login / Signup

Non-invasive urine markers for the differentiation between RCCs and oncocytoma.

Melanie von BrandensteinJan HerdenBarbara KöditzManuel HuertaTim NestlerAxel HeidenreichJochen W U Fries
Published in: Journal of clinical laboratory analysis (2021)
Both proteins (Vim3 and Mxi-2) were detectable in patients' urines and can be used for the non-invasive differentiation of kidney cancers.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors
  • patient reported outcomes